comparemela.com

Latest Breaking News On - Johnm burke - Page 2 : comparemela.com

Janet Elaine Burke

New and Anticipated Advances Across Hematologic Malignancies Necessitate Improved Navigation of Current Options

John M. Burke, MD, expands on the use of novel BTK inhibitor regimens in mantle cell lymphoma, treatment sequencing challenges and other unmet needs in diffuse-large B-cell lymphoma, the evolution of management strategies for myeloproliferative neoplasms, and the potential influence of new and emerging therapeutics in chronic lymphocytic leukemia.

vimarsana © 2020. All Rights Reserved.